Changes to the website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: , which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4700

Next 25



	Website Changes

	10/17/2018		PVSRIPO (Polio Vaccine) clinical trial now open in 4 brain tumor centers!

	10/12/2018		Checkpoint Blockade Reverses Anergy in IL-13Ra2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.


	10/12/2018		Bevacizumab: Is the lower the better for glioblastoma patients in progression?

	10/12/2018		Live Facebook Event about Optune on Oct 22, 2018


	10/04/2018		Novocure Announces 55 Presentations at European Association of Neuro-Oncology Meeting 2018

	09/20/2018		Experimental drug `nothing short of miraculous` for father of 4 with super-rare brain tumor


	09/17/2018		Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.

	09/14/2018		Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition.


	09/14/2018		Brain Tumor Webinar Series: Gamma Knife Radiosurgery Sunday, 9/16/18

	09/13/2018		Moleculin’s Brain Cancer Drug Candidate Begins Patient Dosing at Clinical Trial Being Conducted at MD Anderson


	09/13/2018		Researchers make breakthrough in understanding aggressive brain cancer

	09/10/2018		Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series


	09/10/2018		NCI and Musella Foundation Award Grants for ONC201 Trials in Adult and Pediatric Brain Tumors

	09/10/2018		Patient Foundation Collaboration to Advance ONC201 in DIPG and other H3 K27M-mutant Gliomas


	09/06/2018		KKCO - Daybreak Anchor Sarah Schwabe`s Connection To Glioblastoma

	09/06/2018		Optune Open House: St. Louis, MO


	09/04/2018		Musella Foundation Copay Assistance Program is now open!

	09/04/2018		Dellann Elliott Mydland, President of the EndBrainCancer Initiative, to Serve on Two National Clinical Trial Committees for NRG Oncology, an NCI-Funded Research Group


	09/01/2018		This brain cancer drug stock has been on a tear

	08/29/2018		Optune open house Seattle, WA


	08/27/2018		Aspirin affects tumor angiogenesis and sensitizes human glioblastoma endothelial cells to temozolomide, bevacizumab, and sunitinib impairing VEGF-related signaling.

	08/24/2018		New glioblastoma clinical trial: mTOR inhibitor ABI-009


	08/24/2018		Tocagen`s Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned First Interim Analysis

	08/23/2018		Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.


	08/23/2018		Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations